• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    33 Stocks Moving In Monday's Mid-Day Session

    2/14/22 12:01:32 PM ET
    $AGFY
    $ASAX
    $BDSI
    $BHG
    Farming/Seeds/Milling
    Consumer Staples
    Consumer Electronics/Appliances
    Industrials
    Get the next $AGFY alert in real time by email

    Gainers

    • BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shares jumped 51.9% to $5.53. Collegium Pharmaceutical will acquire BioDelivery Sciences International at $5.60 per share in an all-cash transaction, corresponding to an equity value of approximately $604 million.
    • Motus GI Holdings, Inc. (NASDAQ:MOTS) jumped 28.8% to $0.5474 after declining 6% on Friday.
    • Cornerstone Building Brands, Inc. (NYSE:CNR) gained 24.3% to $22.86 as private equity firm CD&R offered to acquire all outstanding shares it does not already own of Cornerstone Building Brands for $24.65 per share in cash.
    • Knightscope, Inc. (NASDAQ:KSCP) surged 23.2% to $7.78 after the company announced a partnership with Allied Universal to provide autonomous security robots.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares gained 22.8% to $2.6050. The company’s shares dropped 50% on Friday after the company priced its IPO at $4.25 per ADS.
    • Astrea Acquisition Corp. (NASDAQ:ASAX) surged 16.4% to $9.74 after the company, HotelPlanner and Reservations.com mutually agreed to terminate their business combination agreement.
    • Kelly Services, Inc. (NASDAQ:KELYA) jumped 15.6% to $19.95 after the company reported Q4 earnings results.
    • Collegium Pharmaceutical, Inc. (NASDAQ:COLL) surged 14.3% to $20.10 after the company announced it will acquire BioDelivery Sciences.
    • Reliance Global Group, Inc. (NASDAQ:RELI) gained 12.8% to $6.60.
    • Freshworks Inc. (NASDAQ:FRSH) surged 10.4% to $20.32. Freshworks recently reported Q4 earnings results.
    • BioVie Inc. (NASDAQ:BIVI) surged 9.5% to $3.45.
    • VTEX (NYSE:VTEX) gained 9.2% to $8.27. Credit Suisse initiated coverage on Vtex with a Neutral rating and announced a price target of $10.
    • UserTesting, Inc. (NYSE:USER) jumped 8.3% to $9.32. UserTesting is expected to announce Q4 financial results on February 28, 2022.
    • DiDi Global Inc. (NYSE:DIDI) gained 7.3% to $4.28. Bernstein initiated coverage of DiDi Global with an Outperform rating and $6.20 price target, implying an upside of 55.4%.

    Also check out this: Insiders Buying These 4 Penny Stocks

    Losers

    • Dave Inc. (NASDAQ:DAVE) shares dipped 34% to $6.15. Dave recently appointed Michael Pope to Board of Directors.
    • RumbleON, Inc. (NASDAQ:RMBL) dropped 29.2% to $27.25 as the company disclosed senior management changes. The company’s President Peter Levy will succeed Mark Tkach as COO.
    • Bright Health Group, Inc. (NYSE:BHG) declined 23% to $2.94. Bright Health Group is expected to report Q4 financial results on Wednesday, March 2, 2022.
    • Sea Limited (NYSE:SE) dropped 17.6% to $130.40. JP Morgan maintained Sea with an Overweight and lowered the price target from $420 to $250.
    • Gravity Co., Ltd. (NASDAQ:GRVY) fell 16.2% to $51.78. Gravity reported prelim FY21 consolidated revenue of KRW414 billion.
    • Weber Inc. (NYSE:WEBR) fell 16.1% to $8.76 after the company reported worse-than-expected Q1 EPS and sales results.
    • Modular Medical, Inc. (NASDAQ:MODD) fell 15% to $3.62. Modular Medical shares jumped around 15% on Friday following its recent uplisting to the Nasdaq Capital Market on Thursday.
    • InterCure Ltd. (NASDAQ:INCR) shares fell 14.6% to $7.00 after jumping 22% on Friday. Intercure recently reported preliminary Q4 revenue.
    • BRC Inc. (NYSE:BRCC) dipped 13.6% to $14.06.
    • Moderna, Inc. (NASDAQ:MRNA) dropped 12.9% to $140.52. The European Medicines Agency's safety committee is reviewing reports of heavy menstrual bleeding and absence of menstruation after COVID-19 vaccines from Pfizer / BioNTech, and Moderna.
    • Agrify Corporation (NASDAQ:AGFY) fell 11.7% to $7.51.
    • Leafly Holdings, Inc. (NASDAQ:LFLY) dipped 10.5% to $6.36.
    • HeartCore Enterprises, Inc. (NASDAQ:HTCR) shares fell 10.1% to $3.7112. HeartCore Enterprises recently priced its IPO at $5 per share.
    • Novavax, Inc. (NASDAQ:NVAX) dropped 9.4% to $81.95. Novavax recently said that its two-dose COVID-19 vaccine was 80% overall effective against COVID-19 in a late-stage trial testing the shot in teens aged 12 to 17 years.
    • IceCure Medical Ltd (NASDAQ:ICCM) shares fell 8.5% to $2.66. IceCure Medical recently said it sees preliminary FY21 revenues of $4.1 million, up from $3.9 million year-over-year.
    • CF Industries Holdings, Inc. (NYSE:CF) dropped 8% to $70.38.
    • Standard Lithium Ltd. (NYSE:SLI) fell 8% to $5.92. Hindenburg Research recently issued a bearish report on Standard Lithium.
    • Senseonics Holdings, Inc. (NYSE:SENS) fell 6.8% to $2.2550. The FDA recently approved the company’s Eversense E3 Continuous Glucose Monitoring (CGM) System.
    • Zosano Pharma Corporation (NASDAQ:ZSAN) fell 6% to $0.2072. Zosano Pharma recently announced pricing of a $15.4 million public offering of common stock and warrants.

    Also check out this: Discover Financial Services And 3 Other Stocks Sold By Insiders

    Get the next $AGFY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGFY
    $ASAX
    $BDSI
    $BHG

    CompanyDatePrice TargetRatingAnalyst
    CF Industries Holdings Inc.
    $CF
    2/4/2026$72.00Neutral → Sell
    Rothschild & Co Redburn
    Freshworks Inc.
    $FRSH
    2/3/2026$12.00Overweight → Neutral
    Piper Sandler
    Moderna Inc.
    $MRNA
    1/28/2026$25.00Equal Weight
    Barclays
    VTEX
    $VTEX
    1/15/2026$4.00Buy → Neutral
    UBS
    Moderna Inc.
    $MRNA
    1/7/2026$34.00Neutral
    UBS
    Freshworks Inc.
    $FRSH
    12/17/2025Neutral
    BTIG Research
    Moderna Inc.
    $MRNA
    12/12/2025$30.00Hold
    Jefferies
    Collegium Pharmaceutical Inc.
    $COLL
    12/9/2025$58.00Overweight
    Barclays
    More analyst ratings

    $AGFY
    $ASAX
    $BDSI
    $BHG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Integr Cust Growth Offcr Yamamoto Mika was granted 90,140 shares, increasing direct ownership by 8% to 1,181,561 units (SEC Form 4)

    4 - Freshworks Inc. (0001544522) (Issuer)

    2/5/26 5:13:14 PM ET
    $FRSH
    Computer Software: Prepackaged Software
    Technology

    Chief Financial & Oper Officer Sloat Tyler was granted 110,466 shares, increasing direct ownership by 8% to 1,557,793 units (SEC Form 4)

    4 - Freshworks Inc. (0001544522) (Issuer)

    2/5/26 5:12:01 PM ET
    $FRSH
    Computer Software: Prepackaged Software
    Technology

    CEO & President Woodside Dennis was granted 265,119 shares, increasing direct ownership by 10% to 3,003,609 units (SEC Form 4)

    4 - Freshworks Inc. (0001544522) (Issuer)

    2/5/26 5:10:48 PM ET
    $FRSH
    Computer Software: Prepackaged Software
    Technology

    $AGFY
    $ASAX
    $BDSI
    $BHG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dave Reports Preliminary Fourth Quarter and Full Year 2025 Results

    2025 Revenue and Adjusted EBITDA Results are Expected to Exceed the Top-End of Guidance 4Q25 28 DPD Rate Expected to be Within the Range of 1.95%-2.00%, Outperforming Guidance of Below 2.10% Full Earnings Results and 2026 Financial Outlook to Be Discussed on March 2, 2026 at 5:00pm ET LOS ANGELES, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced certain preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025. The Company expects to release full, audited financial results and file its annual report on Form 10-K for the year ended December 31, 2025 on Mar

    2/5/26 4:15:00 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    The $71 Billion Cancer Shift: Why The FDA Is Speeding Up

    VANCOUVER, British Columbia, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The market is waking up to a $71 billion reality[1]. We are seeing a decisive move away from broad chemotherapy and toward precision biologics like mRNA and oncolytic viruses. The FDA is actively accelerating this cycle, having granted multiple breakthrough designations in January 2026 alone for platforms that demonstrate genuine survival durability[2]. This structural realignment positions Oncolytics Biotech Inc. (NASDAQ:ONCY), Moderna (NASDAQ:MRNA), Immunome (NASDAQ:IMNM), Autolus Therapeutics (NASDAQ:AUTL), and Prelude Therapeutics (NASDAQ:PRLD) within the emerging biological innovation c

    2/5/26 9:26:03 AM ET
    $AUTL
    $IMNM
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Knightscope Retains Lake Street to Support Growth Through Acquisitions

    Knightscope, Inc. (NASDAQ:KSCP), a security technology company building the Nation's first Autonomous Security Force, today announced that it has retained Lake Street Capital Markets, a full-service investment bank, as its exclusive buy-side financial advisor to support the Company's growth strategy through acquisitions of complementary businesses, technologies, and capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205409078/en/ This engagement reflects Knightscope's ongoing efforts to strengthen its market position and accelerate growth through selective, disciplined acquisitions aligned with its long-term strateg

    2/5/26 9:00:00 AM ET
    $KSCP
    Telecommunications Equipment
    Telecommunications

    $AGFY
    $ASAX
    $BDSI
    $BHG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CF Industries downgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn downgraded CF Industries from Neutral to Sell and set a new price target of $72.00

    2/4/26 8:27:16 AM ET
    $CF
    Agricultural Chemicals
    Industrials

    Freshworks downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Freshworks from Overweight to Neutral and set a new price target of $12.00

    2/3/26 6:53:05 AM ET
    $FRSH
    Computer Software: Prepackaged Software
    Technology

    Barclays resumed coverage on Moderna with a new price target

    Barclays resumed coverage of Moderna with a rating of Equal Weight and set a new price target of $25.00

    1/28/26 7:18:07 AM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGFY
    $ASAX
    $BDSI
    $BHG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Taslitz Steven bought $129,430 worth of shares (100,000 units at $1.29) (SEC Form 4)

    4 - BRC Inc. (0001891101) (Issuer)

    11/19/25 4:04:54 PM ET
    $BRCC
    Beverages (Production/Distribution)
    Consumer Staples

    Director Taslitz Steven bought $128,450 worth of shares (100,000 units at $1.28), increasing direct ownership by 28% to 451,184 units (SEC Form 4)

    4 - BRC Inc. (0001891101) (Issuer)

    11/14/25 4:41:23 PM ET
    $BRCC
    Beverages (Production/Distribution)
    Consumer Staples

    Director Steven Edelman bought $65,500 worth of shares (10,000 units at $6.55), increasing direct ownership by 15% to 74,708 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/13/25 4:48:53 PM ET
    $SENS
    Medical/Dental Instruments
    Health Care

    $AGFY
    $ASAX
    $BDSI
    $BHG
    SEC Filings

    View All

    SEC Form 10-Q filed by BioVie Inc.

    10-Q - BIOVIE INC. (0001580149) (Filer)

    2/6/26 5:01:18 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Moderna Inc.

    SCHEDULE 13G/A - Moderna, Inc. (0001682852) (Subject)

    2/6/26 1:10:23 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Dave Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Dave Inc./DE (0001841408) (Filer)

    2/5/26 4:19:17 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    $AGFY
    $ASAX
    $BDSI
    $BHG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 3, 2023 - FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants

    For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO

    10/3/23 2:56:27 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AGFY
    $ASAX
    $BDSI
    $BHG
    Leadership Updates

    Live Leadership Updates

    View All

    Dave Inc. Appoints Nima Khajehnouri to Board of Directors; Announces Board Leadership Transitions

    LOS ANGELES, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced that Nima Khajehnouri, a distinguished leader in artificial intelligence and data engineering, has joined its Board of Directors, effective immediately. Mr. Khajehnouri will serve as a member of the Company's Audit Committee. Imran Khan, who has served on the Board since August 2023, is stepping down in conjunction with this appointment. Mr. Khajehnouri brings more than two decades' experience of leading engineering at some of the world's most influential technology companies. He currently serves as Vice President of Engineering at Meta, h

    1/20/26 5:27:46 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    Freshworks Appoints Kady Srinivasan as Chief Marketing Officer

    SAN MATEO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Freshworks (NASDAQ:FRSH), today announced Kady Srinivasan has joined as its Chief Marketing Officer, bringing over 15 years of leadership experience driving large-scale marketing transformations at high-growth SaaS companies. Srinivasan will lead Freshworks' global marketing strategy to amplify the company's mission to deliver exceptional customer and employee experiences with uncomplicated service software. Srinivasan will report to Mika Yamamoto, who serves as Freshworks' Chief Integrated Customer Growth Officer, and continues to oversee Marketing, Customer Support, and the Small Business and Commercial Sales and Customer Success organ

    1/7/26 8:00:00 AM ET
    $FRSH
    $LSPD
    Computer Software: Prepackaged Software
    Technology

    Ragnarok Online Landverse America - Now Live in Latin America and North America

    BANGKOK, Dec. 19, 2025 /PRNewswire/ -- Maxion Tech Co., Ltd. is pleased to announce the official launch of Ragnarok Online Landverse America under an official license from GRAVITY Co., Ltd. (NASDAQGM:GRVY). Launched on December 18, 2025, the game brings the iconic Ragnarok Online universe into the Web3 era, blending classic MMORPG gameplay with blockchain-based item ownership and a player-driven economy. Prior to launch, the game offered pre-registration and pre-sale events starting November 13, 2025, allowing early supporters to access exclusive in-game packages and prepare f

    12/19/25 5:42:00 AM ET
    $GRVY
    Real Estate

    $AGFY
    $ASAX
    $BDSI
    $BHG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by RumbleOn Inc.

    SC 13D/A - RumbleOn, Inc. (0001596961) (Subject)

    12/10/24 9:00:06 PM ET
    $RMBL
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Agrify Corporation

    SC 13D/A - Agrify Corp (0001800637) (Subject)

    11/29/24 4:30:03 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Agrify Corporation

    SC 13D/A - Agrify Corp (0001800637) (Subject)

    11/29/24 4:30:03 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    $AGFY
    $ASAX
    $BDSI
    $BHG
    Financials

    Live finance-specific insights

    View All

    Dave Reports Preliminary Fourth Quarter and Full Year 2025 Results

    2025 Revenue and Adjusted EBITDA Results are Expected to Exceed the Top-End of Guidance 4Q25 28 DPD Rate Expected to be Within the Range of 1.95%-2.00%, Outperforming Guidance of Below 2.10% Full Earnings Results and 2026 Financial Outlook to Be Discussed on March 2, 2026 at 5:00pm ET LOS ANGELES, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced certain preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025. The Company expects to release full, audited financial results and file its annual report on Form 10-K for the year ended December 31, 2025 on Mar

    2/5/26 4:15:00 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    Kelly Announces Fourth-Quarter and Full-Year 2025 Conference Call

    TROY, Mich., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Kelly, a leading global specialty talent solutions provider, will release its fourth-quarter and full-year earnings before the market opens on Thursday, February 12, 2026. In conjunction with its earnings release, Kelly will publish a financial presentation and host a live webcast of a conference call with financial analysts at 9 a.m. ET on February 12 to review the results from the quarter and answer questions. The presentation and a link to the live webcast will be accessible through the Company's public website on the Investor Relations page under Events & Presentations. The webcast will be recorded, and a replay will be available within o

    2/5/26 7:30:00 AM ET
    $KELYA
    $KELYB
    Professional Services
    Consumer Discretionary

    Core Natural Resources to Announce Fourth Quarter 2025 Results on February 12

    CANONSBURG, Pa., Jan. 30, 2026 /PRNewswire/ -- Core Natural Resources, Inc. (NYSE:CNR) will discuss its fourth quarter 2025 financial results on an investor conference call on Thursday, February 12, 2026 at 10:00 a.m. Eastern time. Interested participants may access the conference call by dialing 800-836-8184 approximately five to 10 minutes prior to the start time. For participants calling from an overseas location, please dial +1 646-357-8785. No passcode is needed. The call will also be webcast and will be accessible via the "investor" section of the Core website at http://

    1/30/26 8:30:00 AM ET
    $CNR
    Coal Mining
    Energy